Allosterix Pharmaceuticals

Developing Highly Selective Peptide-based Inhibitors

Health Tech & Life Sciences
Non Active, Dec 2012
Pre-Funding Shilat, Israel Founded 2007
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2007
Headcount
1
HQ
Shilat, Israel
Sector
Health Tech & Life Sciences

About

Allosterix Pharmaceuticals has developed a patent-pending technology for locating allosteric sites andpeptidic drug design. The companys approach to drug design involves creating inhibitors based on the principles of allostery. The advantage of this approach is greater specificity, as selectivity is inherent in each peptidic inhibitor. Allosteric sites are located distal to the active site, in nonconserved regions of the enzyme. By designing drugs for these regions, researchers can produce inhibitors with unprecedented selectivity profiles. This is a departure from previous drug design strategies aimed at inhibiting enzymatic functions. These allosteric inhibitors show little to no reactivity with other enzymes, even very closely related enzymes. This translates into a low incidence of unwanted side effects or toxicity, giving an allosteric inhibitor a significantly higher chance of success at the clinical stage. Allosterix Pharmaceuticals LLC is currently part of Silicon Slopes, a nonprofit organization and start-up greenhouse located in Lehi, Utah, USA.

Q&A

What is the primary focus of Allosterix Pharmaceuticals?
Allosterix Pharmaceuticals focuses on developing highly selective peptide-based inhibitors using a patent-pending technology for locating allosteric sites and peptidic drug design.
What is the key advantage of Allosterix Pharmaceuticals' drug design approach?
The key advantage of Allosterix Pharmaceuticals' approach is greater specificity and selectivity, as their allosteric inhibitors show little to no reactivity with other enzymes, leading to a low incidence of unwanted side effects or toxicity.
When was Allosterix Pharmaceuticals founded?
Allosterix Pharmaceuticals was founded in July 2007.
What is the current status of Allosterix Pharmaceuticals?
Allosterix Pharmaceuticals is currently inactive, as of December 2012.
How many employees does Allosterix Pharmaceuticals have?
Allosterix Pharmaceuticals has 1-10 employees.
Where is Allosterix Pharmaceuticals headquartered?
Allosterix Pharmaceuticals is headquartered in Shilat, Israel.
Does Allosterix Pharmaceuticals hold any patents?
Yes, Allosterix Pharmaceuticals holds one patent.
What is Allosterix Pharmaceuticals' current funding stage?
Allosterix Pharmaceuticals is in the Pre-Funding stage.

Team · 2

Founder · Co-Founder & CEO
LinkedIn ↗
Founder · Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

drug-designbiopharmaceuticalpharma-companieslaboratories
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/15735883

Identifiers & details

Founded2007-7
Employees (exact)1
OfficesLehi
Status reasonNon Active, Dec 2012